Dating the rise of esophageal adenocarcinoma: Analysis of connecticut tumor registry data, 1940-2007

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 1, 2011, Pages 183-185

  Abrams, Julian A ^a,b   Sharaiha, Reem Z ^a   Gonsalves, Lou ^c   Lightdale, Charles J ^a,b   Neugut, Alfred I ^a,b,d  

^a Department of Medicine   (United States)

^b Columbia University ^*  (United States)

^c Connecticut Department of Public Health ^*  (United States)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CARCINOGENESIS; DATA ANALYSIS; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; MALE; MICROBIOME; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; TREND STUDY; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CONNECTICUT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SEER PROGRAM; TIME FACTORS;

EID: 78651425497     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0802     Document Type: Article

References (25)

1. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184-7.
2. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 2009;18:1945-52.
3. Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, et al. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89. Cancer Causes Control 1992;3:481-92.
4. Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008;57:173-80.
5. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008;1:329-38.
6. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010;139:73-83.
7. Roush GC, Holford TR, Schymura MJ, White C. Cancer risk and incidence trends: the Connecticut perspective. Washington, DC: Hemisphere Publishing Corporation; 1987.
8. Heston JF, Kelly JA, Meigs JW, Flannery JT. Forty-five years of cancer incidence in Connecticut, 1935-79. NCI Monogr 1986;70:1-31.
9. US Population Data Downloads. 2010 [cited 2010 April 1]. Available from: http://seer.cancer.gov/popdata/download.html.
10. Surveillance, Epidemiology, and End Results (SEER) Program (www. seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2009 Sub (1973-2007) - Linked To County Attributes - Total U.S., 1969-2007 Counties. April 2010, based on the November 2009 submission ed: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
11. Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402-7.
12. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-3.
13. NHANES MMWR and Short Reports, Body Weight/Obesity. 2010 [cited 2010 April 1]. Available from: http://www.cdc.gov/nchs/nhanes/nhanesmmwrs-obesity. htm.
14. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998;22:39-47.
15. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4:566-72.
16. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168:219-21.
17. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et al. Decreasing prevalence of Helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect 2001;126:37-42.
18. Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, et al. Relationship between Helicobacterpylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734-9.
19. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008;57:1354-9.
20. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesopha-gitis and Barrett's oesophagus. Gut 2008;57:1056-64.
21. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010;105:1007-13; quiz 6, 14.
22. Pei Z, Yang L, Peek RM, Jr Levine SM, Pride DT, Blaser MJ. Bacterial biota in reflux esophagitis and Barrett's esophagus. World J Gastro-enterol 2005;11:7277-83.
23. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl CancerInst 2010;102:1344-53.
24. Giovino GA. Epidemiology of tobacco use in the United States. Oncogene 2002;21:7326-40.
25. Corley DA, Kubo A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 2004;96:1383-7.